Korro Bio director Jean Francois Formela reports sale of $973,609.10 in common shares

KRRO•2026-11-13

Korro Bio director Jean Francois Formela reported selling 66,632 common shares through indirect holdings on Nov. 11-12, 2026, for a reported total of $973,609.10.

Korro Bio director Jean Francois Formela reports sale of $973,609.10 in common shares

1. Share sale details

Related News

Health insurers rise as US temporarily eases Medicaid work-rule enforcement

Indaptus Therapeutics Q3 net loss narrows as R&D costs fall

Cheetah Net Q3 net loss widens 94% to $2.55 million; revenue rises to $3.56 million

Sources

Korro Bio director Jean Francois Formela reports sale of $973,609.10 in common shares

Navient Holdings director Frederick Arnold retires, effective immediately

Healthcare of Ontario pension plan trust fund cuts stakes in Nvidia, Meta and Cisco